Study of histopathologic parameters to define the prognosis of stage II colon cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Study of histopathologic parameters to define the prognosis of stage II colon cancer
Authors
Keywords
Colon cancer, Stage II, Tumor budding, Poorly differentiated cluster, CDX2, Microsatellite instability
Journal
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-03-26
DOI
10.1007/s00384-019-03279-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor budding and poorly-differentiated cluster in prognostication in Stage II colon cancer
- (2018) Victor Wai Kwan Lee et al. PATHOLOGY RESEARCH AND PRACTICE
- Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016
- (2017) Alessandro Lugli et al. MODERN PATHOLOGY
- CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer
- (2016) Piero Dalerba et al. NEW ENGLAND JOURNAL OF MEDICINE
- Left-Sided Early-Onset vs Late-Onset Colorectal Carcinoma
- (2015) Emanuela Pilozzi et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- The number of metastatic lymph nodes exhibiting poorly differentiated clusters predicts survival in patients with pStage III colorectal cancer
- (2015) Osamu Kinoshita et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Tumour budding in colorectal cancer: what do we know and what can we do?
- (2015) Linde De Smedt et al. VIRCHOWS ARCHIV
- Poorly differentiated clusters with larger extents have a greater impact on survival: a semi-quantitative pathological evaluation for 239 patients with non-mucinous pT2-3 colorectal carcinoma
- (2015) Osamu Kinoshita et al. World Journal of Surgical Oncology
- Histologic Categorization of Fibrotic Cancer Stroma in the Primary Tumor Is an Independent Prognostic Index in Resectable Colorectal Liver Metastasis
- (2014) Hideki Ueno et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial
- (2014) D. Klingbiel et al. ANNALS OF ONCOLOGY
- Should the grading of colorectal adenocarcinoma include microsatellite instability status?
- (2014) Christophe Rosty et al. HUMAN PATHOLOGY
- Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) R. Labianca et al. ANNALS OF ONCOLOGY
- New Criteria for Histologic Grading of Colorectal Cancer
- (2012) Hideki Ueno et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Tumor Budding is an Independent Predictor of Outcome in AJCC/UICC Stage II Colorectal Cancer
- (2012) Johannes Betge et al. ANNALS OF SURGICAL ONCOLOGY
- Validation Study of a Quantitative Multigene Reverse Transcriptase–Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer
- (2011) Richard G. Gray et al. JOURNAL OF CLINICAL ONCOLOGY
- Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
- (2011) Gordon Hutchins et al. JOURNAL OF CLINICAL ONCOLOGY
- Microsatellite Instability and Loss of Heterozygosity at Chromosomal Location 18q: Prospective Evaluation of Biomarkers for Stages II and III Colon Cancer—A Study of CALGB 9581 and 89803
- (2011) Monica M. Bertagnolli et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy
- (2011) F. A. Sinicrope et al. JNCI-Journal of the National Cancer Institute
- Proposed Objective Criteria for “Grade 3” in Early Invasive Colorectal Cancer
- (2010) Hideki Ueno et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
- (2010) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor Budding is a Strong and Reproducible Prognostic Marker in T3N0 Colorectal Cancer
- (2008) Lai Mun Wang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now